Your session is about to expire
← Back to Search
Transportation Assistance for Liver Transplant Patients (TAP-LT Trial)
N/A
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
TAP-LT Trial Summary
This trial will test whether using rideshares can help people get to their transplant-related medical appointments.
Who is the study for?
This trial is for adults over 18 who have attended an initial liver transplant clinic visit. It's not open to pregnant women, prisoners, those ineligible for a transplant after the first evaluation, or without a Phase 2 referral. Participants must live within 60 miles of Keck Hospital and be able to consent.Check my eligibility
What is being tested?
The study is testing if providing Lyft rides helps patients attend medical appointments related to liver transplants more reliably. This includes visits with doctors, lab tests, and imaging needed before being put on the waitlist for a transplant.See study design
What are the potential side effects?
Since this trial offers transportation assistance rather than medication, there are no direct medical side effects. However, participants may experience issues like delays or discomfort associated with using the provided transportation service.
TAP-LT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to waitlisting for liver transplant
Secondary outcome measures
Number of hospitalizations
Number of no-shows/cancellations
Patient satisfaction with care
+5 moreTAP-LT Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Transportation assistance, reports unreliable transportationExperimental Treatment1 Intervention
Lyft rides provided to transplant-related appointments
Group II: Transportation assistance, controlActive Control1 Intervention
No intervention, standard-of-care
Group III: No transportation assistance, reports unreliable transportationActive Control1 Intervention
No intervention, standard-of-care
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,258 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have attended a clinic visit for Phase 1 or Phase 1/2 Liver Transplant.I was told I can't have a liver transplant after my first check-up.I am unable to understand or sign the consent form.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Transportation assistance, reports unreliable transportation
- Group 2: Transportation assistance, control
- Group 3: No transportation assistance, reports unreliable transportation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research study actively recruiting participants?
"According to clinicaltrials.gov, this medical examination is no longer accepting patients. It was initially posted on the 24th of January 2022 and amended two days later; however, there are currently 52 other trials actively recruiting for participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger